162 related articles for article (PubMed ID: 6243178)
1. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
2. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
3. Measurement of circulating prostacyclin.
Haslam RJ; McClenaghan MD
Nature; 1981 Jul; 292(5821):364-6. PubMed ID: 7019720
[No Abstract] [Full Text] [Related]
4. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
5. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
6. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
7. Prostacyclin prolongs viability of washed human platelets.
Blackwell GJ; Radomski M; Vargas JR; Moncada S
Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
[TBL] [Abstract][Full Text] [Related]
8. Biological actions of prostacyclin and its pharmacological use in platelet studies.
Moncada S; Whittle BJ
Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
[No Abstract] [Full Text] [Related]
9. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
[No Abstract] [Full Text] [Related]
10. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
11. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
12. Modified sensitivity of diabetic platelets to prostacyclin.
Bonne C; Romquin N; Regnault F
Bibl Anat; 1979; (18):98-103. PubMed ID: 227357
[No Abstract] [Full Text] [Related]
13. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
15. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.
Szczeklik A; Gryglewski RJ; Nizankowski R; Musiał J; Pietoń R; Mruk J
Pharmacol Res Commun; 1978 Jun; 10(6):545-56. PubMed ID: 358212
[No Abstract] [Full Text] [Related]
16. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
Bonne C; Martin B; Watada M; Regnault F
Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
[No Abstract] [Full Text] [Related]
17. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Bussolino F; Camussi G
Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
[TBL] [Abstract][Full Text] [Related]
18. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
Sokolov EI; Lavrenova NIu; Goloborodova IV
Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
[TBL] [Abstract][Full Text] [Related]
19. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
Briel RC; Lippert TH
Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
[TBL] [Abstract][Full Text] [Related]
20. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
Weithmann KU
Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
